共 154 条
[1]
Cosnes J(2011)Epidemiology and natural history of inflammatory bowel diseases Gastroenterology 140 1785-1794
[2]
Gower-Rousseau C(2013)Incidence of inflammatory bowel disease in the province of Styria, Austria, from 1997 to 2007: a population-based study J Crohn’s Colitis 7 58-69
[3]
Seksik P(2012)Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 119-124
[4]
Cortot A(2010)Immunomodulators for all patients with inflammatory bowel disease? Therap Adv Gastroenterol 3 31-42
[5]
Petritsch W(1995)A controlled double blind study of azathioprine in the management of Crohn’s disease Gut 37 674-678
[6]
Fuchs S(1995)Azathioprine and 6-mercaptopurine in Crohn Disease. A meta-analysis Ann Intern Med 123 132-142
[7]
Berghold A(2009)Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis Am J Gastroenterol 104 2089-2096
[8]
Jostins L(2010)The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management J Crohn’s Colitis 4 28-62
[9]
Ripke S(1980)Treatment of Crohn’s disease with 6-mercaptopurine. A long-term, randomized, double-blind study N Engl J Med 302 981-987
[10]
Weersma RK(1993)Long-term experience with 6-mercaptopurine in the treatment of Crohn’s disease Am J Gastroenterol 88 1198-1205